Medscape

Scleroderma Patient has 'World First' Double Hand Transplant

A man in Scotland whose hands were left unusable by scleroderma has been given a new lease of life after what is believed to be the world’s first double hand transplant for the condition. Steven ...
Business Wire

Paracrine Receives FDA Approval to Launch a U.S. Pivotal Trial in Patients With Hand Dysfunction Due to Diffuse Cutaneous Scleroderma

Pivotal trial to support marketing approval of regenerative cells processed with the Celution® System to commence in Q2 2022 SAN DIEGO--(BUSINESS WIRE)--Paracrine, Inc. announced today that the FDA ...
IFLScience

World-First Double Hand Transplant For A Scleroderma Patient Allows Man To Pet His Dog Again

IFLScience needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time.
Business Wire

Paracrine Announces Publication of STAR Trial, Including Improvement in Hand Function and Quality of Life in Patients With Diffuse Cutaneous Scleroderma

SAN DIEGO--(BUSINESS WIRE)--Paracrine, Inc., announced today the online publication (ahead of print) of the findings from the STAR I trial in Arthritis & Rheumatology Journal, the official journal of ...
Science Daily

Drugs showing promise in cancer trials reduce scarring for scleroderma

Epigenetic drugs that have shown promise in cancer trials significantly reduce scarring in the cells of patients with scleroderma, a new study shows. Results reveal that drugs that inhibit BRD4, known ...